发明名称 COMPOSITIONS FOR THE TREATMENT OF CANCER COMPRISING A TOPOISOMERASE INHIBITOR AND THALIDOMIDE
摘要 This invention relates to compositions comprising thalidomide and another anti-cancer drug which can be used in the treatment or prevention of cancer. Preferred anti-cancer drugs are topoisomerase inhibitors. A particular composition comprises thalidomide, or a pharmaceutically acceptable salt, solvate, or clathrate thereof, and irinotecan. The invention also relates to methods of treating or preventing cancer which comprise the administration of a thalidomide and another anti-cancer drug to a patient in need of such treatment or prevention. The invention further relates to methods of reducing or avoiding adverse side effects associated with the administration of chemotherapy or radiation therapy which comprise the administration of thalidomide to a patient in need of such reduction or avoidance.
申请公布号 EP1307197(B1) 申请公布日期 2006.04.05
申请号 EP20010935373 申请日期 2001.05.10
申请人 CELGENE CORPORATION 发明人 ZELDIS, JEROME, B.;ZEITLIN, ANDREW;BARER, SOL
分类号 A61K31/47;A61K45/00;A61K31/445;A61K31/454;A61K31/4745;A61K31/7056;A61K31/724;A61P35/00;A61P43/00 主分类号 A61K31/47
代理机构 代理人
主权项
地址